Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)

NCT01402843 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT01402843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01402843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)
Lead sponsor
JW Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2011
Completion date
January 31, 2013
Enrollment
150 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hypertension